SecBot SecBot
SECBOTREPLAY Home › Report › KURA

KURA · Kura Oncology is holding its annual shareholder meeting to vote on…

Kura Oncology, Inc. · DEFA14A filed Apr 10, 2026 at 16:35 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 10, 2026 at 16:35 ET

Kura Oncology is holding its annual shareholder meeting to vote on director elections, auditor appointment, executive compensation, and equity plan amendments. This is a routine filing with no material financial impact.

  • Kura Oncology is holding its annual shareholder meeting on June 4, 2026
  • Shareholders will vote on the election of three Class III directors
  • The board recommends ratification of Ernst & Young as independent auditors
  • The board recommends approval of executive compensation (Say-on-Pay)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access